Login

Cerevel Therapeutics Holdings, Inc. 4 SEC Filings

Filed On Filing
05 Aug 2024 Form 4: Pfizer Inc, Former 10% Owner

Disposed of 27,349,211 shares (Tender Offer) ($1.23B)

05 Aug 2024 Form 4: Bain Capital Investors Llc, Director and 4 others

Returned 65,679,781 shares to the issuer

05 Aug 2024 Form 4: Gordon Christopher R, Director

Returned 65,693,524 shares to the issuer · Disposed of 80,189 Stock Option (Right to Buy) (Disposition to Issuer)

05 Aug 2024 Form 4: Koppel Adam, Director

Returned 65,693,524 shares to the issuer · Disposed of 80,189 Stock Option (Right to Buy) (Disposition to Issuer)

05 Aug 2024 Form 4: Sanchez Ramiro, Chief Medical Officer

Returned 14,673 shares to the issuer · Disposed of 1,393,153 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 87,573 Restricted Stock Units (Disposition to Issuer)

05 Aug 2024 Form 4: Giordano Douglas E., Director

Returned 13,743 shares to the issuer · Disposed of 95,242 Stock Option (Right to Buy) (Disposition to Issuer)

05 Aug 2024 Form 4: Renaud Ronald C Jr, Director

Returned 244,309 shares to the issuer · Disposed of 215,749 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 284,023 Restricted Stock Units (Disposition to Issuer) · 1 more

05 Aug 2024 Form 4: Mckernan Ruth, Director

Returned 13,743 shares to the issuer · Disposed of 92,986 Stock Option (Right to Buy) (Disposition to Issuer)

05 Aug 2024 Form 4: Akamine Scott, Chief Legal Officer

Returned 7,527 shares to the issuer · Disposed of 367,126 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 59,171 Restricted Stock Units (Disposition to Issuer)

05 Aug 2024 Form 4: Sulzberger Gabrielle, Director

Returned 58,876 shares to the issuer · Disposed of 95,242 Stock Option (Right to Buy) (Disposition to Issuer)

05 Aug 2024 Form 4: Renger John, Chief Scientific Officer

Returned 6,370 shares to the issuer · Disposed of 778,418 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 102,634 Restricted Stock Units (Disposition to Issuer)

05 Aug 2024 Form 4: DiPietro Kenneth, Chief Human Resources Officer

Returned 25,042 shares to the issuer · Disposed of 711,827 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 63,905 Restricted Stock Units (Disposition to Issuer)

05 Aug 2024 Form 4: Tregoning Kathleen, See Remarks

Returned 10,666 shares to the issuer · Disposed of 614,428 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 59,171 Restricted Stock Units (Disposition to Issuer)

05 Aug 2024 Form 4: Dekkers Marijn E, Director

Returned 444,609 shares to the issuer · Disposed of 95,242 Stock Option (Right to Buy) (Disposition to Issuer)

05 Aug 2024 Form 4: Altschuller Susan, Chief Financial Officer

Returned 16,913 shares to the issuer · Disposed of 124,168 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 81,065 Restricted Stock Units (Disposition to Issuer)

05 Aug 2024 Form 4: Riedel Norbert G, Director

Returned 56,553 shares to the issuer · Disposed of 95,242 Stock Option (Right to Buy) (Disposition to Issuer)

05 Aug 2024 Form 4: Bodenrader Mark, See Remarks

Returned 17,724 shares to the issuer · Disposed of 277,817 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 24,852 Restricted Stock Units (Disposition to Issuer)

05 Aug 2024 Form 4: Patrick Deval L, Director

Returned 13,743 shares to the issuer · Disposed of 49,794 Stock Option (Right to Buy) (Disposition to Issuer)

05 Aug 2024 Form 4: Coles N Anthony, Director

Returned 25,928 shares to the issuer · Disposed of 4,809,418 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 46,322 Restricted Stock Units (Disposition to Issuer)

05 Aug 2024 Form 4: Burgess Paul D., See Remarks

Returned 45,727 shares to the issuer · Disposed of 95,931 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 81,065 Restricted Stock Units (Disposition to Issuer)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support